Clinical Studies: The Metabolic Syndrome and Central Obesity

Drs. George E. Dailey, III and Erminia M. Guarneri

Recognize and manage conditions associated with the metabolic syndrome; Explain the role of the endocannabinoid system in regulating body weight; Understand the role of cannabinoid type-1 (CB1) agonists for treatment of obesity; Evaluate risk factors in cardiovascular disease; and Employ therapeutic strategies to reduce risks for cardiovascular disease.